Ligand · H7I
H7I · (4~{S})-5-[(2~{S})-2-(2-azanyl-2-oxidanylidene-ethyl) pyrrolidin-1-yl]-4-(methylamino)-5-oxidanylidene-pentanoic acid
H7I, (4~{S})-5-[(2~{S})-2-(2-azanyl-2-oxidanylidene-ethyl) pyrrolidin-1-yl]-4-(methylamino)-5-oxidanylidene-pentanoic acid (C12 H21 N3 O4, 271.3 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry). Every binding…
- Component
- H7I
- Formula
- C12 H21 N3 O4
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
H7I in 1 structure; the first of them:
- 7XJO · Crystal structure of human mmp-2 catalytic domain in complex with inhibitor · H7I C13 · binds PHE5, PRO6, ARG7, TYR74, PHE87, ALA88, PRO89, THR91 and 3 more
Residues it binds most
PHE 2, PRO 2, GLY 2, ALA 2, ARG 2, LEU 2, THR 2, TYR 2, VAL 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.